Acro Biomedical Co., Ltd.
ACBM
$0.00
-$0.10-99.33%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 746.32% | 52.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 746.32% | 52.81% | |||
| Operating Income | -746.32% | -52.81% | |||
| Income Before Tax | -655.13% | -51.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -655.13% | -51.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -655.13% | -51.46% | |||
| EBIT | -746.32% | -52.81% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -566.67% | -50.00% | |||
| Normalized Basic EPS | -500.00% | -100.00% | |||
| EPS Diluted | -566.67% | -50.00% | |||
| Normalized Diluted EPS | -500.00% | -100.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||